keyword
https://read.qxmd.com/read/38739910/training-family-medicine-residents-in-dermoscopy-using-an-e-learning-course-pilot-interventional-study
#1
JOURNAL ARTICLE
Pauline Friche, Lionel Moulis, Aurélie Du Thanh, Olivier Dereure, Claire Duflos, Francois Carbonnel
BACKGROUND: Skin cancers are the most common group of cancers diagnosed worldwide. Aging and sun exposure increase their risk. The decline in the number of dermatologists is pushing the issue of dermatological screening back onto family doctors. Dermoscopy is an easy-to-use tool that increases the sensitivity of melanoma diagnosis by 60% to 90%, but its use is limited due to lack of training. The characteristics of "ideal" dermoscopy training have yet to be established. We created a Moodle (Moodle HQ)-based e-learning course to train family medicine residents in dermoscopy...
May 13, 2024: JMIR Formative Research
https://read.qxmd.com/read/38739763/treating-epidermolytic-ichthyosis-and-ichthyosis-with-confetti-with-epidermal-autografts-cultured-from-revertant-skin
#2
JOURNAL ARTICLE
Kana Tanahashi, Michihiro Kono, Takenori Yoshikawa, Yuika Suzuki, Masukazu Inoie, Yachiyo Kuwatsuka, Fumie Kinoshita, Takuya Takeichi, Masashi Akiyama
BACKGROUND: No efficient treatment has been established yet for epidermolytic ichthyosis (EI) caused by pathogenic variants in KRT1 or KRT10. Patients with ichthyosis with confetti (IWC) show multiple normal-appearing spots, caused by the revertant somatic recombination of pathogenic variants that occurs at each spot independently. Additionally, some patients with EI have large areas of normal skin due to revertant postzygotic mosaicism. OBJECTIVE: To assess the feasibility transplanting cultured epidermal autografts (CEAs) produced from revertant epidermal keratinocytes in patients with EI and IWC...
May 13, 2024: British Journal of Dermatology
https://read.qxmd.com/read/38739743/mutational-profiling-of-primary-cutaneous-cd4-small-medium-t-cell-lymphoproliferative-disorders-do-not-resemble-nodal-peripheral-t-cell-lymphomas-with-follicular-helper-t-cell-phenotype
#3
JOURNAL ARTICLE
Marta Rodríguez, Marcos Rebollo-González, Jesús Frutos Díaz-Alejo, Rebeca Manso, Francisco Javier Díaz de la Pinta, Juan Torre-Castro, Socorro María Rodríguez-Pinilla
No abstract text is available yet for this article.
May 13, 2024: British Journal of Dermatology
https://read.qxmd.com/read/38739726/qualitative-investigation-of-disease-course-characteristics-and-lived-experience-of-generalized-pustular-psoriasis
#4
JOURNAL ARTICLE
Emily A Parks, Mallory L Zaino, Bettina Trettin, Steven R Feldman
BACKGROUND: Generalized pustular psoriasis (GPP) is a relapsing-remitting chronic disease characterized by painful pustules with systemic symptoms that negatively impacts quality of life. The psychosocial and economic burden of this rare condition is not well characterized. OBJECTIVES: To qualitatively characterize the cumulative burden of generalized pustular psoriasis on patients' quality of life and psychosocial wellbeing. METHODS: A retrospective chart review of patients with generalized pustular psoriasis was performed to collect demographic information, followed by prospective semi-structured clinical interviews...
May 13, 2024: Clinical and Experimental Dermatology
https://read.qxmd.com/read/38739703/psychosocial-comorbidities-in-patients-with-pediatric-alopecia-areata-a-literature-review
#5
JOURNAL ARTICLE
Zane Sejdiu, Samantha Hess, Mohammad Jafferany
BACKGROUND: Alopecia areata (AA), a chronic autoimmune disorder causing non-scarring hair loss, has a greater prevalence in the pediatric population. Like many visible dermatologic disorders, AA can cause significant psychosocial impairment, particularly in children who are undergoing critical periods of psychosocial development. This paper investigates the psychosocial impact of AA on children. METHODS: A systematic review was conducted using PRISMA guidelines...
May 13, 2024: Clinical and Experimental Dermatology
https://read.qxmd.com/read/38739692/disseminated-verrucous-and-keratotic-plaques-in-a-young-boy
#6
JOURNAL ARTICLE
Kittu Malhi, Sukhdeep Singh, Debajyoti Chatterjee, Dipankar De, Sanjeev Handa, Rahul Mahajan
No abstract text is available yet for this article.
May 13, 2024: Clinical and Experimental Dermatology
https://read.qxmd.com/read/38739553/exploring-the-burden-of-actinic-keratoses-through-development-of-a-patient-decision-aid-a-mixed-methods-study
#7
JOURNAL ARTICLE
Ciara Drumm, Aoife Moloney, Louise Fleming, Imelda Morgan, Ciara Keating, Clodagh Hughes, Roisin Dolan, Bláithín Moriarty, Aoife Lally
BACKGROUND: Actinic keratoses (AKs) present on sun-exposed sites and are considered precursors of cutaneous squamous cell carcinoma (cSCC). A better understanding of the experiences of patients with this condition may improve patient-provider relationships and guide the introduction of shared-decision making (SDM) to treatment decisions. OBJECTIVES: To develop a patient decision aid (PDA) for field treatment of multiple actinic keratoses in line with the International Patient Decision Aid Standards (IPDAS), by (i) characterising the burden and lived experiences of patients with multiple AKs, (ii) understanding the decisional needs of patients requiring field treatment and (iii) exploring clinician preferences regarding field treatment for multiple AKs...
May 13, 2024: Clinical and Experimental Dermatology
https://read.qxmd.com/read/38739215/enthesitis-and-dactylitis-resolution-with-risankizumab-for-active-psoriatic-arthritis-integrated-analysis-of-the-randomized-keepsake-1-and-2-trials
#8
JOURNAL ARTICLE
Shawn G Kwatra, Saakshi Khattri, Ahmad Z Amin, Roberto Ranza, Blair Kaplan, Linyu Shi, Byron Padilla, Ahmed M Soliman, Dennis McGonagle
INTRODUCTION: The presence (vs absence) of enthesitis/dactylitis is associated with greater psoriatic arthritis (PsA) activity and reduced health-related quality of life. Risankizumab, an interleukin 23 antagonist, demonstrated superior treatment efficacy over placebo in patients with PsA, including enthesitis/dactylitis. Herein, we report the efficacy of risankizumab on complete resolution of enthesitis and/or dactylitis and improvements in patient-reported outcomes in patients with PsA...
May 13, 2024: Dermatology and Therapy
https://read.qxmd.com/read/38739059/plantar-skin-a-callus-design
#9
JOURNAL ARTICLE
Jack Hayes, Claire A Higgins
No abstract text is available yet for this article.
May 13, 2024: Journal of Investigative Dermatology
https://read.qxmd.com/read/38738774/apremilast-decreased-proinflammatory-cytokines-and-subsequently-increased-inhibitory-ones-in-psoriasis-a-prospective-cohort-study
#10
JOURNAL ARTICLE
Takemichi Fukasawa, Asako Yoshizaki-Ogawa, Atsushi Enomoto, Shinichi Sato, Ayumi Yoshizaki
No abstract text is available yet for this article.
May 13, 2024: Acta Dermato-venereologica
https://read.qxmd.com/read/38738773/validation-of-the-recap-of-atopic-eczema-recap-measurement-instrument-for-eczema-control-in-adult-patients-in-an-asian-clinical-setting
#11
JOURNAL ARTICLE
Yik Weng Yew, Crystal Zhen Yu Phuan, Xiahong Zhao, Laura Howells, Christian J Apfelbacher
Recap of atopic eczema (RECAP) is a self-reported 7-item questionnaire recommended by the Harmonising Outcome Measures in Eczema initiative to measure eczema control. As RECAP has not been validated in a real-world clinical population in Asia, RECAP was investigated as a measure of eczema control in Singapore. Patients with atopic eczema at the National Skin Centre from July 2019 to January 2020 were included for analysis. Both patient- and physician-reported outcome measures were available for correlation analyses...
May 13, 2024: Acta Dermato-venereologica
https://read.qxmd.com/read/38738772/based-on-immune-microenvironment-and-genomic-status-exploring-immunotherapy-in-advanced-hidradenocarcinoma-a-retrospective-analysis
#12
JOURNAL ARTICLE
Jing Lin, Li Zhu, Yanping Chen, Qian Li, Zhiheng Ke, Huishan Zhang, Yufang Huang, Jianping Lu, Yu Chen
There are no standard treatment guidelines for hidradenocarcinoma, and the immune microenvironment and genomic data are very limited. Thus, in this study the immune microenvironment and genomic indicators in hidradenocarcinoma was investigated, and immunotherapy for hidradenocarcinoma was initially explored. Forty-seven hidradenocarcinoma patients were retrospectively collected. Immunohistochemical staining was performed to identify CD3/CD8+ T cells and programmed death ligand-1 expression. In total, 89.4% and 10...
May 13, 2024: Acta Dermato-venereologica
https://read.qxmd.com/read/38738771/vogt-koyanagi-harada-syndrome-following-covid-19-mrna-vaccination-th2-to-th1-transition-related-molecular-machinery
#13
JOURNAL ARTICLE
Yasuaki Ikuno, Akihiko Yamaguchi, Toshifumi Takahashi, Noriki Fujimoto
No abstract text is available yet for this article.
May 13, 2024: Acta Dermato-venereologica
https://read.qxmd.com/read/38738770/impact-of-atopic-dermatitis-on-adult-women-s-lives-a-survey-of-1-009-french-women
#14
JOURNAL ARTICLE
Anne Claire Fougerousse, Marina Alexandre, Anne Sophie Darrigade, Stéphanie Merhand, Adrien Marquié, Medhi Hamza, Gaelle Le Fur, Marie Jachiet, Anne Claire Bursztejn, Charles Taieb
Atopic dermatitis (AD) is one of the most common inflammatory diseases, and has a higher prevalence among females in adulthood. The aim of this observational, cross-sectional, survey-based study was to evaluate the impact of AD on the daily lives of adult women patients. A scientific committee composed exclusively of women constructed a specific questionnaire in partnership with the French Eczema Association. Severity of AD was evaluated with the Patient-Oriented Eczema Measure (POEM). A sample of 1,009 adult women (mean age ± standard deviation: 41...
May 13, 2024: Acta Dermato-venereologica
https://read.qxmd.com/read/38738706/real-world-outcomes-in-patients-with-chronic-spontaneous-urticaria-receiving-omalizumab-insights-from-a-clinical-practice-survey
#15
JOURNAL ARTICLE
Arpamas Seetasith, Michael Holden, James Hetherington, Aaron Keal, Phoebe Salmon, Jonathan A Bernstein, Thomas B Casale
Objective: Chronic spontaneous urticaria (CSU) is a debilitating inflammatory skin condition, often impacting quality of life. International guidelines recommend omalizumab, an anti-immunoglobulin E antibody, for second-line treatment. Our objective was to understand patient characteristics associated with prescription of omalizumab, and assess real-world outcomes in patients with CSU treated with omalizumab. Methods: We analyzed data from the Adelphi Real World CSU Disease Specific Programme™, a cross-sectional survey with retrospective data collection (December 2020-October 2021) from physicians and patients with CSU in the United States...
May 13, 2024: Current Medical Research and Opinion
https://read.qxmd.com/read/38738687/sun-exposure-and-protection-habits-self-reported-attitudes-knowledge-and-behaviours
#16
JOURNAL ARTICLE
Henry W Lim, Marketa Saint Aroman, Charbel Skayem, Bruno Halioua, Nuria Perez Cullell, Yaron Ben Hayoun, Catherine Baissac, Christina Bergqvist, Charles Taieb, Marie-Aleth Richard, Khaled Ezzedine
BACKGROUND: As exposure to UV radiation is the primary modifiable environmental risk factor associated with skin cancer, it remains the principal focus of most prevention strategies. Numerous sun protection campaigns have been implemented worldwide; however, their impact on the actual incidence and mortality rates of skin cancer seems to be limited. To create successful skin cancer prevention campaigns, it is important to have a comprehensive understanding of individuals' attitudes and behaviours regarding sun protection...
May 13, 2024: Journal of the European Academy of Dermatology and Venereology: JEADV
https://read.qxmd.com/read/38738666/sentinel-lymph-node-biopsy-versus-observation-in-high-risk-cutaneous-squamous-cell-carcinoma-in-immunosuppressed-and-immunocompetent-patients-an-inverse-probability-of-treatment-weighting-study
#17
JOURNAL ARTICLE
Antonio Tejera-Vaquerizo, Álvaro Gómez-Tomás, Ane Jaka, Agustín Toll, María Del Río, Carla Ferrándiz-Pulido, María J Fuente, Cristian Carrasco, Francisco M Almazán-Fernández, Tomás Toledo-Pastrana, Ada Ferrer-Fuertes, Simone Ribero, Gianluca Avallone, Javier Cañueto, Jorge Santos-Juanes, Onofre Sanmartín
BACKGROUND: The survival benefit of sentinel lymph node biopsy (SLNB) in immunocompetent and immunosuppressed patients with high-risk cutaneous squamous cell carcinoma (cSCC) has not been established. OBJECTIVE: To determine whether SLNB improves disease-specific survival (DSS) in high-risk cSCC. Secondary objectives were to analyse disease-free survival, nodal recurrence-free survival and overall survival (OS). METHODS: Multicentre, retrospective, observational cohort study comparing survival outcomes in immunosuppressed and immunocompetent patients treated with SLNB or watchful waiting...
May 13, 2024: Journal of the European Academy of Dermatology and Venereology: JEADV
https://read.qxmd.com/read/38738586/eadv-task-force-pruritus-white-paper-on-chronic-pruritus-and-chronic-prurigo-current-challenges-and-future-solutions
#18
JOURNAL ARTICLE
S Ständer, M P Pereira, C Zeidler, F J Legat, L Misery, L Lönndahl, A P Bewley, E Brenaut, S Bobko, J Elberling, A W M Evers, S Garcovich, U Gieler, M Gonçalo, J Kupfer, J Lambert, A Lvov, M Metz, A Michenko, E Papadavid, A Reich, E Savk, G Schneider, C Schut, E Serra-Baldrich, H F Ständer, J C Szepietowski, J Wallengren, E Weisshaar, M Augustin
Chronic pruritus (CP) is frequent in general medicine and the most common complaint in general dermatology. The prevalence of CP is expected to rise in the future due to the ageing population. The clinical presentation, underlying aetiology and treatment strategy of CP are heterogeneous. Also, individual treatment aims and physical, psychic and economic burdens of patients might vary. Chronic prurigo (CPG) is the most severe disease in the chronic pruritus spectrum, being associated with long-standing scratch-induced skin lesions and a therapy refractory itch-scratch-cycle...
May 13, 2024: Journal of the European Academy of Dermatology and Venereology: JEADV
https://read.qxmd.com/read/38738509/a-solitary-erythematous-plaque
#19
JOURNAL ARTICLE
Nikita Cliff-Patel, Emma Amoafo, Lorette Ffolkes, Victoria Akhras
No abstract text is available yet for this article.
May 13, 2024: Clinical and Experimental Dermatology
https://read.qxmd.com/read/38738507/neuro-sweet-syndrome
#20
JOURNAL ARTICLE
Krishna Thazhatheyil, Marese O'Reilly, Nikolas Rae, Sharon Edwards, Jonathan O'Riordan, Andrew Affleck
No abstract text is available yet for this article.
May 13, 2024: Clinical and Experimental Dermatology
keyword
keyword
612
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.